与法国的中小型企业不同,中国许多中小型企业在转型时期是由经营不善的国营或集体企业经过改制才实行民营化的。在改制过程中,由于体制和遗留问题,使得改制过程出现了各种不同的困惑。久安医药正是在困难和迷惑中成功地实现了民营化经营并在市场中取得了一席之地。 Unlike small and medium-sized enterprises in France, many small and medium-sized enterprises in China were privatized only after they were restructured by underperforming state-owned or collective enterprises during the transition period. During the restructuring process, due to the problems of the system and the legacy, various puzzles have appeared in the restructuring process. It is in this difficulty and confusion that Changan Pharmaceutical successfully managed privatization and gained a place in the market.